Shyam Lal Mudavath
Overview
Explore the profile of Shyam Lal Mudavath including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Dinakar Y, Karole A, Parvez S, Jain V, Mudavath S
Biochim Biophys Acta Gen Subj
. 2023 Jun;
1867(9):130396.
PMID: 37271407
Background: Liposomes are predominantly used sorts of nanocarriers for active a targeted delivery through surface functionalization using targeting ligand. The folate receptors are overexpressed in various cancers including breast cancer...
12.
Yadagiri G, Singh A, Arora K, Mudavath S
Front Med (Lausanne)
. 2023 Jun;
10:1096458.
PMID: 37265481
Visceral leishmaniasis (VL), a vector-borne disease, is caused by an obligate intramacrophage, kinetoplastid protozoan parasite of the genus . Globally, VL is construed of diversity and complexity concerned with high...
13.
Dinakar Y, Karole A, Parvez S, Jain V, Mudavath S
Life Sci
. 2022 Oct;
310:121133.
PMID: 36306866
Lung Cancer (LC) is the malignant tumor of the lungs which is defined by the unrestricted cell development in the lung tissues which if left untreated may migrate to different...
14.
Dinakar Y, Kumar H, Mudavath S, Jain R, Ajmeer R, Jain V
Life Sci
. 2022 Sep;
309:120996.
PMID: 36170890
Introduction: Breast cancer (BC) accounts for the majority of cancers among the female population. Anomalous activation of various signaling pathways has become an issue of concern. The JAK-STAT signaling pathway...
15.
Singh A, Yadagiri G, Javaid A, Sharma K, Verma A, Singh O, et al.
Biomater Sci
. 2022 Aug;
10(19):5669-5688.
PMID: 36017751
Surface-functionalized vitamin B (VB) biocompatible nanoparticles exploit the well-characterized uptake pathway of VB, shielding it from enzymatic degradation and inadequate absorption. In this perspective, subsequent to escalated mucus interaction and...
16.
Singh A, Sharma S, Yadagiri G, Parvez S, Gupta R, Singhal N, et al.
RSC Adv
. 2022 May;
10(46):27502-27511.
PMID: 35516949
is an obligate intracellular protozoan parasite, which resides in human macrophage vacuoles that are referred to as parasitophorus vacuoles. Amphotericin B (AmB) is the first-line drug with 99% cure rates;...
17.
Parvez S, Karole A, Mudavath S
Biochim Biophys Acta Gen Subj
. 2022 May;
1866(8):130157.
PMID: 35500665
Background: In this study, the transport mechanism of fluorescently labeled hydroxypropyl beta-cyclodextrin (HPβ-CD) modified SLNs loaded with Amphotericin B (AmB) and Paromomycin (PM) have been investigated by using in vitro...
18.
Parvez S, Karole A, Mudavath S
Colloids Surf B Biointerfaces
. 2022 Apr;
215:112520.
PMID: 35489319
Nerolidol is a sesquiterpene that occurs naturally and possesses a diverse set of biological characteristics including anticancer activity but has limited solubility, bioavailability, and fast hepatic metabolism. The goal of...
19.
Singh A, Yadagiri G, Negi M, Kushwaha A, Singh O, Sundar S, et al.
Int J Biol Macromol
. 2022 Feb;
204:373-385.
PMID: 35149096
Herein, carboxymethyl chitosan (CMC) grafted lipid nanoformulations were facilely prepared by thin-film hydration method as a highly efficient biocompatible anti-leishmanial carrier encapsulating amphotericin B (AmB). Nanoformulations were characterized for their...
20.
Parvez S, Yadagiri G, Arora K, Javaid A, Kushwaha A, Singh O, et al.
ACS Biomater Sci Eng
. 2021 Aug;
9(6):2902-2910.
PMID: 34463477
In this study, 2-hydroxypropyl-β-cyclodextrin (HPβCD) grafted solid lipid nanoparticle (SLN)-based bioconjugate was synthesized and used for administering a combination of melatonin (Mel) and amphotericin B (AmB) orally for effective visceral...